The National Institutes of Health (NIH) intends to award a non-competitive contract to Oxford Nanopore Technologies Inc. for the supply of 22 packs of promethION flow cells (11 for DNA and 11 for RNA) to support long-read sequencing of experimental sample tissues. The procurement is conducted under simplified acquisition procedures, with the total amount not exceeding the simplified acquisition threshold of $350,000. Performance of services will be at the NIH’s location in Bethesda, Maryland. Interested parties must submit their responses by July 6, 2026, at 9:00 AM Eastern time. This notice is not a request for competitive proposals, but capable sources may submit a capability statement for consideration.